Topic Archives: Oncolytics Biotech (ONCY)

February 25, 2019 / Michael Jorrin, "Doc Gumshoe"

Rapid Response: The Israeli Cure for All Cancers? And a Postscript on Opioids

What set me off on this rant was the very first comment on the piece that posted on January 31st, “Looking Backward – And a Peek in the Other Direction.” Here’s the comment: “Thanks, Doc. Hope you will comment on the news out of Israel this week: https://www.jpost.com/HEALTH-SCIENCE/A-cure-for-cancer-Israeli-scientists-say-they-think-they-found-one-578939” Naturally, I looked, and what I found […]

October 8, 2018 / Michael Jorrin, "Doc Gumshoe"

Cancer: The Lay of the Land in 2018

Putting the name of this imperious disease in the title of my homily places a weighty responsibility on me. Who am I to attempt to put forth relevant information and sensible opinions on this topic, the mere mention of which makes most normal folk distinctly uneasy? But I probably pay more attention to […]

January 27, 2015 / Michael Jorrin, "Doc Gumshoe"

Cancer Care: Where Are We and Where Are We Headed?

[ed note: Michael Jorrin is a longtime medical writer (not a doctor) who covers health and medical topics and trends for our readers, generally without an investment thesis. His words are his own, enjoy!] In the Doc Gumshoe blog about cancer that appeared in June of 2013 (you can check it out here), I commented […]

June 7, 2013 / Michael Jorrin, "Doc Gumshoe"

What’s Happening in Cancer Treatment? Are We Making Progress, or Are We Stuck?

Today we’re sharing another piece from our medical contributor, “Doc Gumshoe” — we have added the stock tickers to the companies he mentions for your researching convenience, but this survey of the state of cancer research — which will hopefully be good background help to folks trying to understand the basic science behind pitches for […]

Comments

Marc on

Discussion page for Arch Therapeutics (ARTH) / May 16, 3:37pm

Hi, I started following KSS here, and moved over to BioPub as well. I have substantial positions in over a dozen of his...

SoGiAm on Biotech Discussion… continued / Nov 9, 7:44am

Oncolytics Biotech® Announces Presentation at the Society for Immunotherapy of Cancer 2018 Annual Meeting Showcasing Up...

SoGiAm on written by reader

#Technology > A Wide Angle Discussion of The Big Picture & It’s Players / Nov 7, 7:00am

Wow, very encouraging data for oncolytic H-1 parvovirus + avastin + PD1 combo in #Glioblastoma at #SNO18 78% ORR: 22% C...

SoGiAm on written by reader

#Technology > A Wide Angle Discussion of The Big Picture & It’s Players / Nov 7, 6:30am

$ONCY Dr. Annels, et al., will present pelareorep data at #SITC2018 showcasing upregulation of PD-L1 expression with reo...

SoGiAm on written by reader

PRE and AFTER Market Discussion Thread ( $XYZ or #Subject REQIUIRED in EACH post, TIA ) / Nov 1, 7:18am

Oncolytics Biotech® Announces Abstract for ASH Annual Meeting & Exposition Demonstrating Pelareorep Increases PD-L1 Exp...

SoGiAm on Biotech Discussion… continued / Oct 30, 6:43am

$ONCY > OV's have shown an ability to turn cold tumors hot. We believe pelareorep will in mBC and excited to start work...

Dr. KSS MD PhD on Dr. KSS Liveblog: Noblecon 14 / Jan 30, 12:43pm

Pvt company: StemImmune. Vaccinia as oncolytic virus play. To cut to the chase, this company is too tentative and specul...